Recursion Pharmaceuticals Competitors and Similar CompaniesClear all

Recursion Pharmaceuticals's competitors and similar companies include G3T, Aegicare, OneThree Biotech and BenevolentAI.

	Recursion Pharmaceuticals Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.	G3T G3 Therapeutics (G3T) is a biotechnology company that focuses on the development of therapeutics.	Aegicare Aegicare is a company that specializes in genetic intelligence to enable precise medical diagnosis and drug research and development.	OneThree Biotech OneThree Biotech is a company that develops an artificial intelligence platform designed to accelerate drug discovery and development.	BenevolentAI BenevolentAI is a company that develops artificial intelligence and machine learning technologies for drug discovery and life sciences.
Founding Date	Founding Date 2013	Founding Date N/A	Founding Date 2017	Founding Date 2018	Founding Date 2013
Type	Type Public	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare artificial intelligence biotech drug development genetics pharma	Tags Healthcare artificial intelligence biotech drug development genetics pharma	Tags Healthcare artificial intelligence biotech drug development genetics healthtech platform	Tags Healthcare Technology artificial intelligence biotech drug development genetics platform	Tags Technology artificial intelligence drug development knowledge management
Locations	Locations Salt Lake City, US HQ	Locations Midlothian, US HQ	Locations Shenzhen, CN HQ Palo Alto, US	Locations New York, US HQ	Locations London, GB HQ Babraham, GB
Employees	Employees 216	Employees 3	Employees 6	Employees 717% increase	Employees 180
Valuation ($)	Valuation ($) 2 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1 b
Financial
Revenue (est.)	Revenue (est.) $74.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €7.3m (FY, 2023)
Cost of goods	Cost of goods $71m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $3.7m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit €7.8m (FY, 2023)
Net income	Net income ($644.8m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income (€63.3m) (FY, 2023)
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 4m (almost 7 years ago)	Latest funding round $ 2.5m (about 6 years ago)	Latest funding round $ 90m (over 6 years ago)
Total funding raised	Total funding raised $ 437.1m	Total funding raised N/A	Total funding raised $ 7.8m	Total funding raised $ 2.5m	Total funding raised $ 305m